Medical Digest & Congress Report
Episodes
The SAXOPHONE Study - report from ISTH2022
21 Jul 2022
Contributed by Lukas
We asked Professor Mark R. Payne about the new results of the SAXOPHONE Study what he presented at the recent ISTH 2022 congress. The study inve...
Current Guidelines on Perioperative Anticoagulation Management: DOACs - report from ISTH2022
20 Jul 2022
Contributed by Lukas
DOACs revolutionize the anticoagulation treatment in the last decade, but we have a few open question yet. We asked Professor James Douketis about the...
Diagnosis and management of non-adherence in hypertension treatment - report from ESH2022
14 Jul 2022
Contributed by Lukas
Professor Jan Václavík held a lecture at the recent European Society of Hypertension 2022 Congress about the diagnosis of non-adherence in antihyper...
Implementation of the 2019 lipid guidelines: where are we now? - report from EAS2022
14 Jul 2022
Contributed by Lukas
Professor Alberico L. Catapano spoke about the European Atherosclerosis Society annual meeting, the novelties presented there, the ESC/EAS joint sessi...
Nocturnal hypertension - report from ESH2022
12 Jul 2022
Contributed by Lukas
At the recent European Society of Hypertension 2022 annual congress, nocturnal hypertension addressed as one of the six hot questions in blood pressur...
Blood pressure management in older frail patients - report from ESH2022
11 Jul 2022
Contributed by Lukas
There are long standing debates around the blood pressure lowering treatment in elderly patients. Fortunately more and more clinical trials incl...
Lifelong burden of hypertension - report from ESH2022
08 Jul 2022
Contributed by Lukas
Professor Giuseppe Mancia spoke about a very interesting session from the recent European Society of Hypertension congress in Athens. The session was ...
New pathogenic insights in chronic urticaria - report from EADV Symposium 2022
06 Jul 2022
Contributed by Lukas
Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights about it at the recent EADV sy...
Novelties in the diagnosis and management of primary aldosteronism - report from ESH2022
21 Jun 2022
Contributed by Lukas
Professor Constantine Stratakis co-chaired a meet the expert session at the 31st European Meeting on Hypertension and Cardiovascular Protection....
Results from the phase 3 PARADIGM trial - report from ASCO2022
16 Jun 2022
Contributed by Lukas
Professor Takayuki Yoshino presented at the recent ASCO 2022 new data about the PARADIGM trial. He summerized us the main findings. (Panitumumab plus ...
Detecting elevated lipoprotein(a) and addressing the ASCVD risks - report from EAS2022
16 Jun 2022
Contributed by Lukas
Professor Florian Kronenberg presented the lipoprotein(a) consensus panel recommendations in the recent European Atherosclerosis Society 2022 Congress...
Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022
15 Jun 2022
Contributed by Lukas
Professor Carl Orringer was a co-chair of a recent symposium at the European Atherosclerosis Society 2022 session in Milan. The topic of the discussio...
Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials? - report from ASCO2022
15 Jun 2022
Contributed by Lukas
Professor Richard D. Kim presented a data about the long term follow-up of the KEYNOTE-651 study at the recent ASCO 2022 congress. We asked him about ...
The difference between the genetic and pharmacological inhibition of PCSK9 - report from EAS2022
10 Jun 2022
Contributed by Lukas
Professor Giuseppe Danilo Norata discussed in the interview what is difference between PCSK9 genetic deficiency and PCSK9 pharmacological inhibition. ...
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - interview with Sibylle Loibl
10 Jun 2022
Contributed by Lukas
Professor Sibylle Loibl was the recipient of the 2022 ESMO Breast Cancer award for her excepcional contribution the clinical research of Breast Cancer...
Long-term efficacy and safety of ixekizumab - interview with Andrew Blauvelt
02 Jun 2022
Contributed by Lukas
Dr. Andrew Blauvelt is the first author of a recent paper which analyzes long-term efficacy and safety of ixekizumab in psoriasis. Dr. Blauvelt tell u...
ESC/EAS joint session: What is new in secondary CV prevention?
02 Jun 2022
Contributed by Lukas
Professor Ulrich Laufs talk about a very challenging topic, secondary cardiovascular prevention. At the European Atherosclerosis Society annual meetin...
ESC/EAS joint session: Advances in CV risk estimation with focus on dyslipidemia - report from EAS2022
31 May 2022
Contributed by Lukas
Professor Ian Graham shared us the advances of the cardiovascular risk collaboration he spoke about of the ESC/EAS joint session at EAS 2022. Video: h...
Treatment options of chronic urticaria - report from EADV Symposium 2022
31 May 2022
Contributed by Lukas
Professor Margarida Gonçalo shared with us one of the session of the recent EADV Symposium took place in Ljubljana. The topic was chronic urticaria. ...
Novelties at the International Summit of Lung Cancer in Rome - report from ISLC2022 in Rome
30 May 2022
Contributed by Lukas
Professor Federico Cappuzzo summarize the program of the Summit held in Rome. During the sessions was discussed various aspects in the field of lung c...
Atrial fibrillation guidelines into clinical practice - report from EHRA2022
03 May 2022
Contributed by Lukas
Professor Daniel Scherr co-chaired a very interesting symposium at the recent EHRA 2022 congress, how the can physicians better use the guidelines. We...
Recent developments of the conduction system pacing - report from EHRA2022
29 Apr 2022
Contributed by Lukas
Professor Hung-Fat Tse is an expert on the field on pacing, and recently co-chaired a very interesting symposium at the EHRA 2022 about the recent dev...
What do new guidelines tell us about conduction system pacing? - report from EHRA2022
28 Apr 2022
Contributed by Lukas
Professor Michael Glikson co-chaired the European Society of Cardiology guidelines on cardiac pacing, and now he speaks for us about the part of this ...
Conduction system pacing: ready for prime time? - report from EHRA2022
28 Apr 2022
Contributed by Lukas
Professor Mauro Biffi speak us about the data that were presented at the recent European Heart Rhythm Association meeting. The session he talking abou...
Antithrombotic Approaches to Reduce the Risk of Secondary Event in CAD and PAD - report from ACC2022
22 Apr 2022
Contributed by Lukas
Professor Marc Bonaca co-moderated a session at the American College of Cardiology meeting that was focused on the care of patients with advanced vasc...
Results from the EMPULSE Trial - report from ACC2022
20 Apr 2022
Contributed by Lukas
Professor Mikhail Kosiborod going to speaking about the additional analysis from the EMPULSE trial that were presented at the American College of Card...
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk - report from ACC2022
14 Apr 2022
Contributed by Lukas
Professor Deepak Bhatt had presented an analysis from the SCORED trial at the American College of Cardiology Annual Sessions as a late-breaking clinic...
Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment - interview with Federico Cappuzzo
14 Apr 2022
Contributed by Lukas
Professor Federico Cappuzzo gave us an update on the emerging data on the field of lung cancer. There are very important news that were presented duri...
Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People - report from ACC2022
14 Apr 2022
Contributed by Lukas
Professor Deepak Bhatt gave us a brief recap of some data he presented at the ACC Late-Braker session. He presented data about a drug know as Bentraci...
Protecting comorbid patients with atrial fibrillation from stroke - report from EHRA2022
11 Apr 2022
Contributed by Lukas
Professor John Camm recently attended the European Heart Rhythm Association annual congress. One of the session he involved in wanted to group t...
How to reduce limb events including amputations in our patients? - report from ACC2022
08 Apr 2022
Contributed by Lukas
Professor Manesh Patel speak about how to reduce limb events, amputations and making our patients limbs to better with peripheral arterial disease. Vi...
Guidance in Heart Failure Care at ACC 2022 - report from ACC2022
08 Apr 2022
Contributed by Lukas
Professor David Lanfear summarize the key interesting things from the American College of Cardiology 2022 Scientific sessions in the topic. Video: htt...
EHRA scientific documents 2022 - report from EHRA2022
08 Apr 2022
Contributed by Lukas
Professor Cecilia Linde gave us an update from the European Heart Rhythm Association conference from Copenhagen on four topics regarding the EHRA scie...
Updated Cumulative Results of Treatment With Mavacamten From the EXPLORER-LTE Cohort of the MAVA-LTE Study - report from ACC2022
06 Apr 2022
Contributed by Lukas
Professor Florian Rader presented this year at ACC 2022 the results of the MAVA-LTE Study. As the backdrop of this study, Hypertrophic Cardiomyopathy ...
The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott
10 Mar 2022
Contributed by Lukas
Prof. David F. McDermott shared his thoughts in the kidney cancer filed. What was the biggest changes in the last six months? Video: https://congressr...
How will the current therapeutic options change the treatment of RCC in the daily practice? - interview with Camillo Porta
10 Mar 2022
Contributed by Lukas
Prof. Camillo Porta shared his thoughts on the ASCO GU 2022 meeting which focused on the renal cell carcinoma updates. Which were those changes what w...
Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma - interview with Stefan N. Symeonides
08 Mar 2022
Contributed by Lukas
Professor Stefan N. Symeonides gave us a talk about the results from 30-month follow-up of KEYNOTE-564. Video: https://congressreport.eu/scientific-co...
Treatment intensification in the treatment of prostate cancer - interview with Oliver Sartor
08 Mar 2022
Contributed by Lukas
Professor Oliver Sartor gave us a talk about the newer concepts around the treatment intensification in prostate cancer, focus a little bit on the new...
First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer - interview with Ken Kato
01 Mar 2022
Contributed by Lukas
Professor Ken Kato gave us a talk about longer-term efficacy, safety, and quality-of-life results from the phase 3 KEYNOTE-590 study. Video: https://c...
State of the art treatment of bladder cancer - interview with Matthew R. Zibelman
01 Mar 2022
Contributed by Lukas
Professor Matthew R. Zibelman gave us updates in bladder or urothelial cancers after the recent ASCO GU symposium 2022 from San Francisco. Video: http...
Treatment of iron deficiency in acute and chronic heart failure - interview with Piotr Ponikowski
11 Feb 2022
Contributed by Lukas
Professor Piotr Ponikowski gave us a talk about iron deficiency in heart failure in the context of prevalence, clinical significance and potential the...
Alcohol septal ablation in hypertrophic cardiomyopathy: past and future - interview with Hubert Seggewiss
09 Feb 2022
Contributed by Lukas
Professor Hubert Seggewiss gave us a talk about alcohol septal ablation in hypertrophic cardiomyopathy. Video: https://congressreport.eu/scientific-co...
The use of SGLT2 inhibitors in the prevention and treatment of heart failure - interview with Petar Seferovic
07 Feb 2022
Contributed by Lukas
Professor Petar Seferovic gave us a talk on the new drugs and strategies regarding the heart failure. He spoke about SGLT2 inhibitors too, which are o...
Direct myosin inhibitors in hypertrophic cardiomyopathy: a new era? - interview with Iacopo Olivotto
03 Feb 2022
Contributed by Lukas
Professor Iacopo Olivotto gave us a talk on new developments about myosin inhibitors and that use in hypertrophic cardiomyopathy. Last year they prese...
Diagnostic delay in pulmonary arterial hypertension - interview with Bodil Ivarsson and Barbro Kjellström
20 Jan 2022
Contributed by Lukas
Diagnostic delays in pulmonary arterial hypertension are related to increased morbidity and mortality. The risk of a delayed, or even a missed, diagno...
Clinical Impact of Liraglutide as a Treatment of Obesity - interview with Babak Dehestani
18 Jan 2022
Contributed by Lukas
In this review, Dr. Babak Dehestani aim to explain the mechanism of action of Liraglutide, its pharmacokinetic properties, its clinical impact on obes...
Association of GLP 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events - interview with Michael Camilleri
17 Jan 2022
Contributed by Lukas
Professor Michael Camilleri gave us a review on the topic. Video: https://congressreport.eu/scientific-contents/standalonecontent:association-glp-1-an...
Novelties in the treatment of multiple myeloma 2021 - report from ASH2021
20 Dec 2021
Contributed by Lukas
Professor Andrzej Jakubowiak speak about the novelties and state of the art treatment presented at ASH 2021. Video: https://congressreport.eu/scientif...
Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology - report from ASH2021
20 Dec 2021
Contributed by Lukas
Interview with professor Lisa K. Hicks: Patients with blood cancers, particularly those with more advanced disease, are at increased risk for serious ...
Novelties in the treatment of myelofibrosis and polycythemia vera 2021 - report from ASH2021
20 Dec 2021
Contributed by Lukas
Professor Srdan Verstovsek speak about the novelties and state of the art treatment presented at ASH 2021. Video: https://congressreport.eu/scientific...
Highlights of the San Antonio Breast Cancer Symposium 2021 - report from SABCS2021
20 Dec 2021
Contributed by Lukas
Professor Virginia Kaklamani speak about the novelties and state of the art treatment presented at SABCS 2021. Video: https://congressreport.eu/scient...
Antibody Response to Vaccination with Myeloid and Lymphoid Neoplasms - report from ASH2021
17 Dec 2021
Contributed by Lukas
Professor Susanne Saussele speaks about antibody response to vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid N...
Final results of KEYNOTE-355 - report from SABCS2021
16 Dec 2021
Contributed by Lukas
Professor Javier Cortes speaks about the final results of KEYNOTE-355 trial, a Randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy...
Results from the Randomized Phase 3 Transform Study - report from ASH2021
16 Dec 2021
Contributed by Lukas
Professor Manali Kamdar speaks about Lisocabtagene Maraleucel, a CD19-Directed Chimeric Antigen Receptor T Cell Therapy, Versus Standard of Care with ...
Novelties on the treatment of non-Hodgkin lymphoma - report from ASH2021
16 Dec 2021
Contributed by Lukas
The main topics that Professor Umberto Vitolo speaks about: CAR T-cell studies, POLARIS study, R-CHOP timing. Video: https://congressreport.eu/scienti...
Correlative analysis of overall survival by intrinsic subtype across the MONALEESA-2, -3, and -7 studies - report from SABCS2021
16 Dec 2021
Contributed by Lukas
Professor Lisa A. Carey speaks about the MONALEESA-2, -3, and -7 trials of ribociclib + endocrine therapy in patients with HR+/HER2− advanced breast...
PALLAS trial: Adjuvant palbociclib in HR+/HER2- early breast cancer - report from SABCS2021
15 Dec 2021
Contributed by Lukas
Professor Michael Gnant speaks about the final results from 5,760 patients in the randomized phase III PALLAS trial. Video: https://congressreport.eu/...
The DESTINY-Breast03 trial - report from SABCS2021
14 Dec 2021
Contributed by Lukas
Professor Sara Hurvitz speaks about trastuzumab deruxtecan vs. trastuzumab emtansine in patients with HER2+ metastatic breast cancer. Video: https://c...
Liraglutide for Weight Management in the Real World - interview with Roman Vangoitsenhoven
03 Dec 2021
Contributed by Lukas
Prof. Roman Vangoitsenhoven speaks about a newly published research paper in Obesity Facts sheds light on the real-world effectiveness and practicalit...
Clinical Impact of Liraglutide as a Treatment of Obesity - interview with Alexander Miras
17 Nov 2021
Contributed by Lukas
Dr. Alexander Miras is a senior lecturer and consultant in endocrinology at Imperial College London, known expert in the field of pediatric medicine. ...
The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction - interview with Michael Nauck
17 Nov 2021
Contributed by Lukas
Prof. Michael A. Nauck has a long clinical experience with GLP-1 analogs, author of several scientific papers about their applications. Video: h...
The role of SGLT2 inhibitors in the treatment of diabetes with cardiovascular disease - report from EASD2021
22 Oct 2021
Contributed by Lukas
Prof. Mikael Rydén speak about the state-of-the-art treatment of the disease. Video: https://congressreport.eu/scientific-contents/interview:current-...
The current issues in Hypoglycaemia - report from EASD2021
19 Oct 2021
Contributed by Lukas
Prof. Brian Frier speak about the latest findings on the treatment of the disease. Video: https://congressreport.eu/scientific-contents/interview:curr...
Current guidelines on diabetes management - report from EASD2021
13 Oct 2021
Contributed by Lukas
Prof. Christoph Wanner speaks about the latest guidelines and findings on treatment and comprehensive care for diabetes. Video: https://congressreport...
The MONALEESA-2 trial - report from ESMO2021
30 Sep 2021
Contributed by Lukas
Prof. Gabriel N. Hortobagyi speaks about the overall survival results from the phase III MONALEESA-2 trial of postmenopausal patients with hormone rec...
Spotlight on the emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC) - report from ESMO2021
30 Sep 2021
Contributed by Lukas
Prof. Peter Galle speaks about the the emerging therapies on advanced RCC, HCC and DTC. Video: https://congressreport.eu/scientific-contents/int...
Should Cure Be A Reasonable Goal in aRCC? - report from ESMO2021
23 Sep 2021
Contributed by Lukas
Prof. David F. McDermott speaks about the long-term survival of patients with kidney cancer. Video: https://congressreport.eu/scientific-contents/inte...
The Keynote 716 trial - report from ESMO2021
22 Sep 2021
Contributed by Lukas
Prof. Jason J. Luke speaks about the efficacy and safety results from the Keynote 716 double-blinded phase III trial. Pembrolizumab versus place...
Is Unresectable Malignant Pleural Mesothelioma a New Frontier for I-O? - report from ESMO2021
22 Sep 2021
Contributed by Lukas
Prof. Alessandra Curioni speaks about the update of CheckMate 743 trial. Video: https://congressreport.eu/scientific-contents/interview:unresectable-m...
Highlights of the ESMO 2021 Congress - report from ESMO2021
21 Sep 2021
Contributed by Lukas
Prof. Solange Peters speaks about the most important presentations on ESMO 2021. Video: https://congressreport.eu/scientific-contents/interview:highl...
Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB - report from ESMO2021
21 Sep 2021
Contributed by Lukas
Prof. Wolfgang Janni speaks about the HER2CLIMB study. Video: https://congressreport.eu/scientific-contents/interview:navigating-new-era-her2-metasta...
Metastases-free survival results from STAMPEDE - report from ESMO2021
21 Sep 2021
Contributed by Lukas
Prof. Gerhardt Attard speaks about the STAMPEDE study: Abiraterone acetate and prednisolone or AAP and enzalutamide added to androgen deprivation ther...
Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB - report from ESMO2021
21 Sep 2021
Contributed by Lukas
Prof. Judy King speaks about the treatment of HER2+ Metastatic Breast Cancer. Video: https://congressreport.eu/scientific-contents/interview:navigati...
2021 ESC Guidelines - CVD Prevention - report from ESC2021
12 Sep 2021
Contributed by Lukas
Prof. Frank Visseren speaks about the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Video: https://congressreport.eu...
SSaSS: Salt Substitute and Stroke Study into the effect of salt substitutes on cardiovascular events and death - report from ESC2021
12 Sep 2021
Contributed by Lukas
Professor Bruce Neal introduce the Salt Substitute and Stroke Study, which defines the overall balance of benefits and risks of salt substitutes compa...
Antithrombin Deficiency Registry, an Update - report from ERS2021
10 Sep 2021
Contributed by Lukas
Professor Zsuzsanna Bereczky introduce the Antithrombin Deficiency Registry that was established in 2020. Video: https://congressreport.eu/scientific...
ERS/EAACI statement on adherence to international adult asthma guidelines - report from ERS2021
09 Sep 2021
Contributed by Lukas
Doctor Alexander Mathioudakis summarizes the findings of an ERS/EAACI task force. Video: https://congressreport.eu/scientific-contents/interview:erse...
Pulmonary hypertension and interstitial pulmonary fibrosis - report from ERS2021
09 Sep 2021
Contributed by Lukas
Prof. Vincent Cottin summarizes the main messages about the topic. Video: https://congressreport.eu/scientific-contents/interview:pulmonary-hypertens...
The RIPCORD 2 trial - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Nicholas Curzen speaks about the RIPCORD 2 trial. Does routine pressure wire assessment influence management strategy of coronary angiography fo...
The STEP Study - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Diederick E. Grobbee speaks about intensive vs. standard blood pressure control among older hypertensive patients. Video: https://congressrepor...
2021 ESC Guidelines - Cardiac Pacing - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Michael Glikson speaks about the 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy. Video: https://congressreport.eu/...
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. George Dangas speaks about the outcomes of the ENVISAGE-TAVI AF trial. Video: https://congressreport.eu/scientific-contents/interview:envisage-...
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest - Valvular Heart Disease - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Steffen Desch speaks about the TOMAHAWK trial. This study examined whether immediate coronary angiography in survivors of out-of-hospital cardia...
2021 ESC Guidelines - Valvular Heart Disease - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Friedhelm Beyersdorf speaks about the 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Video: https://congressreport.eu/...
The APAF-CRT Trial - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Michele Brignole speaks about the APAF-CRT Trial, AV junction ablation and CRT in patients with permanent atrial fibrillation and narrow QRS. V...
2021 ESC Guidelines - Cardiac Pacing - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Jens Cosedis Nielsen speaks about the 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy. Video: https://congressrepor...
What is new about Angina? - report from ESC2021
07 Sep 2021
Contributed by Lukas
Prof. Piotr Jankowski speaks about the current management of Angina. Video: https://congressreport.eu/scientific-contents/interview:what-new-about-an...
LOOP Study: screening for AF with an implantable loop recorder to prevent stroke - report from ESC2021
03 Sep 2021
Contributed by Lukas
Prof. Jesper Hastrup Svendsen speaks about the LOOP Study. This study looks at whether continuous ECG monitoring using an implantable loop recorder to...
2021 ESC Guidelines on Heart Failure - report from ESC2021
03 Sep 2021
Contributed by Lukas
Prof. Marco Metra speaks about the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Video: https://congressrep...
The SMART-MI Trial - report from ESC2021
03 Sep 2021
Contributed by Lukas
Prof. Axel Bauer speaks about the SMART-MI-ICMs tiral: implantable cardiac monitors in high-risk, postinfarction patients with cardiac autonomic dysfu...
Abelacimab for Prevention of Venous Thromboembolism - report from ISTH2021
26 Jul 2021
Contributed by Lukas
Prof. Jeffrey Weitz, President of ISTH presented a late-breaking abstract about the medicine Abelacimab. Video: https://congressreport.eu/scient...
State of the art treatment of breast cancer - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Virginia Kaklamani gave us an update what she considered the most important abstract presented at this year's ASCO 2021. Video: https://congress...
State of the art treatment of prostate cancer - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Oliver Sartor speaks about the changes and progress we seen in prostate cancer treatment in the last couple of months. Video: https://congressre...
Clinical decision making in the treatment of melanoma - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Paolo Ascierto speaks about the results of the recent ASCO 2021 novelties in the field of melanoma. Video: https://congressreport.eu/scientific-...
Current state of immunotherapy options in the treatment of RCC - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Camillo Porta talks about the current state of immunotherapy options in the treatment of advanced metastatic renal cell cancer with regard to th...
Current state of immunotherapy options in the treatment of melanoma - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Jeffrey Weber speaks about the important results in melanoma treatment have been announced on ASCO 2021 meeting. Prof. Weber as a renowned exper...
State of the art treatment of breast cancer - report from ASCO2021
26 Jul 2021
Contributed by Lukas
Prof. Jane Meisel speaks about Breast Cancer updates from ASCO 2021. Video: https://congressreport.eu/scientific-contents/interview:state-art-treatmen...
The QUAZAR AML-001 Maintenance Trial - report from EHA 2021
26 Jul 2021
Contributed by Lukas
Prof. Eytan Stein talked about maintenance therapy for acute myeloid leukemia. Video: https://congressreport.eu/scientific-contents/interview:quazar-a...
Novelties in the treatment of Multiple Myeloma - report from EHA 2021
26 Jul 2021
Contributed by Lukas
Prof. Enrique Ocio give us a brief overview about the main messages of the studies presented on EHA 2021 regarding multiple myeloma. Video: https://co...
Harnessing the immune system in multiple myeloma: CAR T-cell therapy and bispecific antibodies - report from EHA 2021
26 Jul 2021
Contributed by Lukas
Prof. Xavier Leleu speaks about the clinical and practical aspects of the topic. Video: https://congressreport.eu/scientific-contents/interview:harnes...